It has the same name and the same active ingredient, but
GlaxoSmithKline claims to have significantly improved its migraine
treatment Imitrex (sumatriptan) with a new formulation that
dissolves rapidly in the stomach.
Israel-based Biodar, a subsidiary of food ingredient company
Lycored, has announced its acquisition of Karma Pharm in a
transaction that boosts its activities in pharmaceuticals.
A small US company has developed an encapsulation technology for
pharmaceuticals that promises to overcome a major healthcare
problem - deaths and illness caused by aspirin and other
non-steroidal anti-inflammatory drugs (NSAIDs).
Irish pharmaceutical group Elan has raised around $70 million
(€55m) from four new deals, including the sale of formulation and
manufacturing interests.
A survey has found that difficulties in swallowing pills is
widespread among adults, but is rarely discussed with doctors and
can prevent some people from taking their medicine. The findings
suggest that pharmaceutical companies should...
Escalating inflation rates and price pressures are hitting the
profit margins of positive displacement pump manufacturers and
inhibiting R&D, says new study.
The market for retractable syringes designed to prevent needlestick
injuries is set for explosive growth and could expand nearly
seven-fold by 2006, according to a new report.
Medisys has terminated its marketing agreement with Smiths Group
for the Futura safety syringe after last week's falling-out which
followed a further delay in the product's launch.
Profile Therapeutics has reported strong growth in sales and a
reduced operating loss for the year-ended June 30, and expects this
trend to continue as its R&D efforts in improved nebuliser
technologies come to fruition.
Chiron's has completed its acquisition of UK vaccine and drug
delivery specialist PowderJect, making it the second-largest
manufacturer of flu vaccines worldwide.
The launch of newer technology products with a wide range of
applications and the facility to deliver proteins, peptides, and
large molecules is expected to rake in market revenues, according
to a new report from market analysts Frost...
Ireland's Elan Corp has inked a deal with Ingenium Pharmaceuticals
of Germany that will see the companies apply Ingenium's functional
genomics technologies to the discovery and development of novel
therapeutics for pain...
British Biotech, once the darling of the UK biotechnology industry
but now suffering the after-effects of a string of major drug
development failures, is having another go at bolstering its
pipeline via a merger with fellow UK company...
Drug target validation has become the critical step in maintaining
profitability for the pharmaceutical industry, claims a new report
from market research company Business Communications. Drug
developers must accelerate identification...
CyDex, a US company working in drug delivery technologies, has
signed announced an agreement with Merck regarding its advanced
formulation system Captisol.
Crosslinking is a natural phenomenon occurring in gelatin that negatively impacts soft capsules, reducing their stability and prolonging their dissolution...
New classes and indications of orally inhaled therapeutics are rapidly expanding, with the development pipeline increasingly featuring both large and small...
Invivo: Many orally dosed APIs are bioavailable only when formulated as an enteric dosage form to protect them from the harsh environment of the stomach....
